Towerpoint Wealth Increases Holdings in Growth ETFs, Tech Stocks Amid Q2 Activity
Towerpoint Wealth LLC boosted its positions in popular Vanguard exchange-traded funds like VUG and VO during Q2 2026, while adding shares to American Centurion ETF TR (AVDV) and Lam Research Corp (LRCX). The investor also increased exposure to specific companies.

Towerpoint Wealth LLC has continued its focus on growth-oriented investments in the second quarter of 2026. Analysis of their portfolio changes shows significant buying activity, particularly within exchange-traded funds focused on technology and innovation.
The largest increase by weight was observed in Vanguard's Information Technology ETF (VUG). Towerpoint Wealth added a substantial number of shares during this period, increasing the fund's holdings from previous quarters. This move suggests confidence in the long-term prospects of the tech sector. Similarly, their position in Vanguard's Core Equity Market ETF (VO) saw considerable growth through share additions.
Additionally, Towerpoint Wealth significantly increased its stake in American Centurion ETF TR (AVDV), a fund tracking the Consumer Staples Select Sector. This addition represents a diversification into this essential goods category and highlights the investor's interest in established consumer sectors with potential for steady returns.
The investment thesis appears to extend beyond broad indices, as evidenced by their purchase of shares in Lam Research Corp (LRCX). This chip equipment manufacturer is a key player in the semiconductor industry. Towerpoint Wealth also added exposure to Kenvue Inc (KVUE), an energy company focused on oil and gas exploration.
While not all changes are major, there were notable adjustments elsewhere. For instance, Vanguard's Small Cap Growth ETF (VGT) allocation increased slightly during Q2 2026, adding another data point to Towerpoint Wealth's interest in smaller companies with growth potential.
In terms of sector focus, despite the specific stock purchases mentioned above, the overall portfolio remains heavily concentrated in 'Unknown' allocations. However, Technology and Healthcare sectors show positive signs through increased ETF holdings (VUG/VO) and direct stock investments respectively (JNJ). The investor's strategy seems to involve a blend of broad market exposure via highly weighted ETFs and targeted additions to specific growth areas.